From Wikipedia, the free encyclopedia
Chemical compound
HU-320 |
|
(3S,4S)-3-[2,6-Dihydroxy-4-(2-methyloctan-2-yl)phenyl]-4-(prop-1-en-2-yl)cyclohex-1-ene-1-carboxylic acid
|
PubChem CID | |
---|
ChemSpider | |
---|
|
Formula | C25H36O4 |
---|
Molar mass | 400.559 g·mol−1 |
---|
3D model (JSmol) | |
---|
O=C(O)/C2=C/[C@H](c1c(O)cc(cc1O)C(C)(C)CCCCCC)[C@@H](\C(=C)C)CC2
|
InChI=1S/C25H36O4/c1-6-7-8-9-12-25(4,5)18-14-21(26)23(22(27)15-18)20-13-17(24(28)29)10-11-19(20)16(2)3/h13-15,19-20,26-27H,2,6-12H2,1,3-5H3,(H,28,29)/t19-,20+/m1/s1 YKey:LDMILSDGSQMZOB-UXHICEINSA-N Y
|
(verify) |
HU-320 (7-nor-7-carboxy-CBD-1,1-DMH) is a drug related to cannabidiol, which has strong antiinflammatory and immunosuppressive properties while demonstrating no psychoactive effects.[1][2]
See also[edit]
References[edit]
|
---|
Phytocannabinoids (comparison) | Cannabibutols | |
---|
Cannabichromenes | |
---|
Cannabicyclols | |
---|
Cannabidiols | |
---|
Cannabielsoins | |
---|
Cannabigerols | |
---|
Cannabiphorols | |
---|
Cannabinols | |
---|
Cannabitriols | |
---|
Cannabivarins | |
---|
Delta-8-tetrahydrocannabinols | |
---|
Delta-9-tetrahydrocannabinols | |
---|
Delta-10-Tetrahydrocannabinols | |
---|
Miscellaneous cannabinoids | |
---|
Active metabolites | |
---|
|
---|
Endocannabinoids | |
---|
Synthetic cannabinoid receptor agonists / neocannabinoids | Classical cannabinoids (dibenzopyrans) | |
---|
Non-classical cannabinoids | |
---|
Adamantoylindoles | |
---|
Benzimidazoles | |
---|
Benzoylindoles | |
---|
Cyclohexylphenols | |
---|
Eicosanoids | |
---|
Hydrocarbons | |
---|
Indazole carboxamides | |
---|
Indazole-3- carboxamides | |
---|
Indole-3-carboxamides | |
---|
Indole-3-carboxylates | |
---|
Naphthoylindazoles | |
---|
Naphthoylindoles | |
---|
Naphthoylpyrroles | |
---|
Naphthylmethylindenes | |
---|
Naphthylmethylindoles | |
---|
Phenylacetylindoles | |
---|
Pyrazolecarboxamides | |
---|
Pyrrolobenzoxazines | |
---|
Quinolinyl esters | |
---|
Tetramethylcyclo- propanoylindazoles | |
---|
Tetramethylcyclo- propanoylindoles | |
---|
Tetramethylcyclo- propylindoles | |
---|
Others | |
---|
|
---|
Allosteric CBR ligands | |
---|
Endocannabinoid enhancers (inactivation inhibitors) | |
---|
Anticannabinoids (antagonists/inverse agonists/antibodies) | |
---|
|